TOWA PHARMACEUTICAL CO.,LTD.【JP:4553】Cash flow
Market cap
¥186.5B
P/E ratio
10.1x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 5,724 | 7,329 | 7,980 | 8,173 | 8,340 | 8,285 | 9,674 | 10,153 | 14,261 | 13,659 | 15,677 |
| Cash from operations | 8,037 | 3,732 | 10,195 | 19,230 | 19,002 | 19,164 | 12,008 | 22,129 | 2,544 | 8,212 | 23,401 |
| Capital expenditures | -13,321 | -13,554 | -20,488 | -14,476 | -11,143 | -4,549 | -9,137 | -11,140 | -28,731 | -37,851 | -28,736 |
| Cash from investing | -8,230 | -19,032 | -22,206 | -20,093 | -3,994 | -39,541 | -9,100 | -59,729 | -30,284 | -40,394 | -31,287 |
| Payments for dividends | -1,275 | -1,755 | -1,558 | -1,557 | -1,559 | -2,067 | -2,166 | -2,411 | -3,100 | -2,952 | -2,953 |
| Repurchases of common stock | - | -5,042 | - | - | - | - | - | - | - | - | - |
| Proceeds from issuance of term debt, net | 4,400 | 22,000 | 3,500 | 9,800 | 5,000 | - | 40,500 | 9,160 | 78,831 | 46,935 | 26,365 |
| Repayments of term debt | -2,971 | -2,505 | -2,033 | -2,681 | -4,249 | -6,396 | -6,895 | -7,181 | -8,118 | -7,607 | -12,482 |
| Cash from financing | 238 | 27,970 | -92 | 4,670 | -809 | 11,748 | 184 | 46,540 | 17,481 | 35,407 | 21,567 |